RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer

NCT00253318 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Toxicity and Lack of Efficacy

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: RAD001
DRUG: Dexamethasone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]